Stifel Financial Corp. The company is headquartered in St. Louis, Missouri.
| Revenue (TTM) | $5.83B |
| Gross Profit (TTM) | $5.58B |
| EBITDA | — |
| Operating Margin | 21.80% |
| Return on Equity | 16.40% |
| Return on Assets | 2.25% |
| Revenue/Share (TTM) | $37.73 |
| Book Value | $35.15 |
| Price-to-Book | 2.33 |
| Price-to-Sales (TTM) | 2.11 |
| EV/Revenue | 2.437 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 50.60% |
| Quarterly Revenue Growth (YoY) | 12.70% |
| Shares Outstanding | $151.00M |
| Float | $145.53M |
| % Insiders | 3.17% |
| % Institutions | 93.48% |
Volatility is currently contracting
ST. LOUIS, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today reported selected operating results for July 31, 2026, to provide timely information to investors on certain key performance metrics. Due to the limited nature of this data, a consistent correlation to earnings should not be assumed.
Stifel has reiterated its 'buy' rating on Faron Pharmaceuticals Limited (AIM:FARN), the Finnish biotech, maintaining a price target of €2.50 after the company's interims, which showed the company well-funded to push on with value-accretive work in the clinic. The stock closed at €0.48 on 25 August, implying upside of 418.1% to the target price.
ST. LOUIS, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today announced that its Board of Directors has declared a cash dividend on shares of its common stock of $0.34 per share, payable September 15, 2026, to shareholders of record at the close of business on September 1, 2026.
Custom Health Holdings Inc (TSX:CHLT) just landed Buy-rated coverage from Stifel, with analysts setting a C$12 price target and pointing to upside as high as C$18 a share. The pitch: a pill-dispensing platform that's quietly solving one of healthcare's most expensive headaches.
Ron Kruszewski, Stifel chairman and ceo, says artificial intelligence will lead to productivity gains. He says financial advisers are still valuable and AI can help them.
Stifel Financial Corp. (SF) Q2 2026 Earnings Call Transcript
Stifel Financial NYSE: SF reported what executives described as the strongest first half in the company's history, with second-quarter revenue and earnings rising from a year earlier as wealth management, investment banking and net interest income all contributed to growth.
Stifel Financial remains a "Buy" despite recent underperformance, with AI-driven cash sweep fears seen as overdone and not reflected in current results. Q2 earnings beat expectations, with revenue up 11% to $1.45 billion and client assets rising 12% to $580 billion, supporting robust wealth management and investment banking momentum. Net interest income, a key profit driver, remains resilient; cash balances are stable, and Fed rate hikes could further benefit SF's earnings.
Stifel Financial (SF) came out with quarterly earnings of $1.42 per share, beating the Zacks Consensus Estimate of $1.35 per share. This compares to earnings of $1.14 per share a year ago.
ST. LOUIS, July 22, 2026 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today reported net revenues of $1.45 billion for the three months ended June 30, 2026, compared with $1.28 billion a year ago. Net income available to common shareholders was $217.2 million, or $1.34 per diluted common share, compared with $145.7 million, or $0.89 per diluted common share (1) for the second quarter of 2025.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on SF and any ticker you trade — then tracks every position and per-strategy win rate.
